Clinical trial
Randomized, Double-blind, Multiple-dose Escalation, Placebo-controlled Phase I Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Pharmacodynamics of VC005 Tablets in Healthy Subjects
NCT05354752 is registered in ClinicalTrials.gov with Jiangsu vcare pharmaceutical technology co., LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Multiple-dose Escalation, Placebo-controlled Phase I Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Pharmacodynamics of VC005 Tablets in Healthy Subjects
- Lead sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 18, 2022
- Completion date
- November 15, 2022
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.